Initial experience of use of tolvaptan in critically ill patients with fluid overload

Journal of Clinical Pharmacy and Therapeutics
J Ruiz-RamosP Ramirez

Abstract

Positive volume balance is related with high mortality in critically ill patients. We describe our experience in the use of tolvaptan in patients with fluid overload. Six patients in the recovery phase from septic shock were included. All patients achieved an increase in diuresis after the first day, with a median fluid balance variation of -2362 (-485 to -3447) mL. At the end of treatment, median fluid balance variation was -9080 (-26,784 to -4395) mL. Tolvaptan could be an option in critically ill patients with fluid overload and resistant or not treatable with conventional diuretics.

References

Sep 30, 2005·Intensive Care Medicine·Anupama UpadyaConstantine A Manthous
Aug 2, 2008·Critical Care : the Official Journal of the Critical Care Forum·Sean M BagshawClaudio Ronco
Jan 21, 2010·Anaesthesia·K M Ho, B M Power
Sep 17, 2011·Contributions to Nephrology·Ravindra L Mehta, Josée Bouchard
Mar 1, 2012·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Nicholas A RogersJennifer A Cuthbert
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Mar 29, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Koichiro KinugawaKazuki Mizuguchi

❮ Previous
Next ❯

Citations

May 19, 2020·European Journal of Hospital Pharmacy. Science and Practice·Jesús Ruiz-RamosÁlvaro Castellanos-Ortega

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Journal of the American Society of Nephrology : CJASN
Morgan E GramsNational Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network
Lille médical : journal de la Faculté de médecine et de pharmacie de l'Université de Lille
E CUINGNET
Rassegna clinico-scientifica
The Journal of Pharmacy and Pharmacology
S E DICKER
© 2022 Meta ULC. All rights reserved